Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibrin Fibrinogen Degradation Products | 6 | 2018 | 9 | 1.370 |
Why?
|
| Emergency Service, Hospital | 8 | 2018 | 259 | 1.240 |
Why?
|
| Pulmonary Embolism | 6 | 2011 | 64 | 0.830 |
Why?
|
| Fibrinolytic Agents | 3 | 2018 | 59 | 0.660 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 36 | 0.580 |
Why?
|
| Colonoscopy | 3 | 2020 | 73 | 0.550 |
Why?
|
| Emergency Medicine | 4 | 2015 | 97 | 0.530 |
Why?
|
| Medical Overuse | 1 | 2015 | 8 | 0.510 |
Why?
|
| Health Policy | 1 | 2015 | 50 | 0.490 |
Why?
|
| African Americans | 1 | 2014 | 1 | 0.460 |
Why?
|
| Premenopause | 1 | 2014 | 11 | 0.460 |
Why?
|
| Postmenopause | 1 | 2014 | 52 | 0.450 |
Why?
|
| Duodenal Diseases | 1 | 2013 | 3 | 0.430 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 5 | 0.430 |
Why?
|
| Vascular Fistula | 1 | 2013 | 4 | 0.430 |
Why?
|
| Abdominal Pain | 1 | 2013 | 8 | 0.430 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 9 | 0.430 |
Why?
|
| Enema | 1 | 2010 | 3 | 0.350 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 43 | 0.340 |
Why?
|
| Exercise | 1 | 2014 | 473 | 0.330 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 81 | 0.320 |
Why?
|
| Critical Pathways | 1 | 2007 | 21 | 0.280 |
Why?
|
| Ischemic Attack, Transient | 1 | 2007 | 17 | 0.280 |
Why?
|
| Enterobius | 1 | 2006 | 1 | 0.260 |
Why?
|
| Enterobiasis | 1 | 2006 | 1 | 0.260 |
Why?
|
| Cecum | 1 | 2006 | 12 | 0.260 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 97 | 0.260 |
Why?
|
| Humans | 20 | 2020 | 28408 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 320 | 0.200 |
Why?
|
| Sensitivity and Specificity | 6 | 2009 | 517 | 0.200 |
Why?
|
| Adult | 6 | 2018 | 8097 | 0.180 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 8 | 0.170 |
Why?
|
| Gastroenterology | 1 | 2020 | 10 | 0.170 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 52 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2014 | 439 | 0.160 |
Why?
|
| Age Factors | 3 | 2018 | 781 | 0.160 |
Why?
|
| Aged | 6 | 2014 | 9262 | 0.150 |
Why?
|
| Middle Aged | 7 | 2014 | 9254 | 0.150 |
Why?
|
| Knowledge | 2 | 2007 | 16 | 0.140 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 85 | 0.140 |
Why?
|
| Health Services Research | 2 | 2015 | 42 | 0.140 |
Why?
|
| Diffusion of Innovation | 2 | 2007 | 32 | 0.140 |
Why?
|
| Male | 9 | 2020 | 15273 | 0.130 |
Why?
|
| Environment | 1 | 2015 | 47 | 0.120 |
Why?
|
| Clinical Decision-Making | 1 | 2015 | 44 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 59 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 80 | 0.120 |
Why?
|
| Risk Factors | 3 | 2018 | 2408 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2008 | 676 | 0.120 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 2 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2014 | 3 | 0.120 |
Why?
|
| E-Selectin | 1 | 2014 | 3 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 730 | 0.120 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 8 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 8 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 51 | 0.110 |
Why?
|
| Female | 8 | 2020 | 15708 | 0.110 |
Why?
|
| Triglycerides | 1 | 2014 | 61 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 53 | 0.110 |
Why?
|
| Cholesterol | 1 | 2014 | 64 | 0.110 |
Why?
|
| Physical Fitness | 1 | 2014 | 57 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 141 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2014 | 61 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2014 | 108 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 11 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2020 | 231 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 372 | 0.100 |
Why?
|
| Headache | 1 | 2012 | 34 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2014 | 465 | 0.090 |
Why?
|
| Time Factors | 1 | 2015 | 1490 | 0.090 |
Why?
|
| Medicare | 1 | 2012 | 121 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2010 | 10 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 166 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2020 | 1805 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 351 | 0.080 |
Why?
|
| Antifibrinolytic Agents | 1 | 2009 | 17 | 0.080 |
Why?
|
| Resuscitation | 1 | 2008 | 15 | 0.080 |
Why?
|
| Cause of Death | 1 | 2008 | 64 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2008 | 39 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2008 | 147 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2007 | 20 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 46 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2007 | 10 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2006 | 21 | 0.070 |
Why?
|
| Sepsis | 1 | 2008 | 144 | 0.070 |
Why?
|
| Calcitonin | 1 | 2006 | 17 | 0.070 |
Why?
|
| ROC Curve | 2 | 2008 | 144 | 0.070 |
Why?
|
| Recurrence | 1 | 2007 | 322 | 0.070 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2005 | 4 | 0.060 |
Why?
|
| Heparin | 1 | 2005 | 22 | 0.060 |
Why?
|
| Bacteremia | 1 | 2006 | 101 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 83 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 44 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2005 | 95 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 352 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 1216 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 65 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2007 | 219 | 0.060 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2003 | 2 | 0.060 |
Why?
|
| Stroke | 1 | 2007 | 276 | 0.050 |
Why?
|
| Critical Illness | 1 | 2005 | 135 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 492 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2010 | 3615 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2003 | 74 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2020 | 249 | 0.050 |
Why?
|
| Learning Curve | 1 | 2020 | 17 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 15 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 137 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 1926 | 0.040 |
Why?
|
| Animals | 1 | 2006 | 3780 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 4853 | 0.040 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 6 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 43 | 0.030 |
Why?
|
| Communication | 1 | 2015 | 124 | 0.030 |
Why?
|
| United States | 2 | 2012 | 2197 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2012 | 128 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 50 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 735 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 34 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 102 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2008 | 69 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 267 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 137 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 11 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 66 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 330 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 196 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 243 | 0.020 |
Why?
|
| Critical Care | 1 | 2008 | 199 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2006 | 268 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 467 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 986 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 356 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 639 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 1663 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 2069 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 3609 | 0.010 |
Why?
|
| Child | 1 | 2006 | 1421 | 0.010 |
Why?
|